Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer? (Q43287327)

18 November 2017

Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer? (English)

1 reference

18 November 2017

Michael Schmuecking

1

1 reference

18 November 2017

Carsten Boltze

2

1 reference

18 November 2017

Hagen Geyer

3

1 reference

18 November 2017

Henning Salz

4

1 reference

18 November 2017

Bert Schilling

5

1 reference

18 November 2017

Thomas G Wendt

6

1 reference

18 November 2017

Karl-Heinz Kloetzer

7

1 reference

18 November 2017

Christiane Marx

8

1 reference

18 November 2017

1 September 2009

1 reference

International Journal of Radiation Biology

18 November 2017

1 reference

18 November 2017

85

1 reference

18 November 2017

9

1 reference

18 November 2017

814-824

1 reference

High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991.

18 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Robust treatment planning for intensity modulated radiotherapy of prostate cancer based on coverage probabilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

[MRI for troubleshooting detection of prostate cancer]

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

[MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging]

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Guidelines for primary radiotherapy of patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Positron emission tomography for radiation treatment planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Imaging prostate cancer: a multidisciplinary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Prostate cancer: precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Radiation dose and late failures in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Shuttling of CTP:Phosphocholine cytidylyltransferase between the nucleus and endoplasmic reticulum accompanies the wave of phosphatidylcholine synthesis during the G(0) --> G(1) transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Endorectal MR imaging before salvage prostatectomy: tumor localization and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Correlation of histologic results with PET findings for tumor regression and survival in locally advanced non-small cell lung cancer after neoadjuvant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Modeling tracer kinetics in dynamic Gd-DTPA MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Deformable image registration for the use of magnetic resonance spectroscopy in prostate treatment planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Tumor physiologic response to combretastatin A4 phosphate assessed by MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

21 January 2018

Prostate cancer imaging

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

Dose painting: art or science?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903090027

10.1080/09553000903090027

21 January 2018

Identifiers

DOI

1 reference

18 November 2017

1 reference